Literature DB >> 10678951

A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.

P McGuirk1, K H Mills.   

Abstract

Protection against infectious pathogens at mucosal surfaces is dependent on local antibody responses, production of inflammatory mediators, and recruitment of immune effector cells to the site of infection. Since Th1 and Th2 cells produce cytokines with pro- and anti-inflammatory activities, immunization with vaccines that induce these T-cell subtypes may regulate the subsequent inflammatory response to infection. We have demonstrated that immunization of mice with pertussis whole-cell or acellular vaccines (Pw or Pa) selectively induces Th1 and Th2 cells, respectively. In this study we have used a murine respiratory-infection model to demonstrate that priming with a Th1- or Th2-inducing pertussis vaccine can influence the local inflammatory response and immune effector cells in the lung following aerosol challenge with Bordetella pertussis. Analysis of bronchoalveolar lavage (BAL) fluid taken during the course of B. pertussis infection of naïve mice or mice immunized with Pw revealed an early influx of neutrophils and local production of interleukin 1beta (IL-1beta) in the lungs. In contrast, neutrophil infiltration and IL-1beta production were not observed following challenge of mice immunized with the Th2-inducing Pa. Conversely, during infection local production of IL-6 and IL-1ra was significantly greater in mice immunized with Pa than in those immunized with Pw. Studies of knockout mice revealed neutrophil and lymphocyte infiltration in the lungs following B. pertussis infection of IL-4-defective (IL-4(-/-)) mice but not in wild-type mice immunized with Pa. Furthermore, the levels of IL-1beta, IL-6, and IL-1ra in Pa-immunized IL-4(-/-) mice were comparable to those in mice immunized with Pw. These results demonstrate distinct influences of Th1- and Th2-inducing vaccines on the protective inflammatory responses in the lungs following challenge with B. pertussis and implicate IL-4 as an important regulator of inflammatory-cell recruitment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678951      PMCID: PMC97292          DOI: 10.1128/IAI.68.3.1383-1390.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis.

Authors:  C E Loscher; S Donnelly; M A Lynch; K H Mills
Journal:  J Neuroimmunol       Date:  2000-01-24       Impact factor: 3.478

2.  IL-4 inhibits the expression of IL-8 from stimulated human monocytes.

Authors:  T J Standiford; R M Strieter; S W Chensue; J Westwick; K Kasahara; S L Kunkel
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

3.  The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.

Authors:  T A Fong; T R Mosmann
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

4.  Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 area health authorities.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

5.  Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

Authors:  E Vannier; L C Miller; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Generation and analysis of interleukin-4 deficient mice.

Authors:  R Kühn; K Rajewsky; W Müller
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

7.  Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.

Authors:  L L Steed; M Setareh; R L Friedman
Journal:  J Leukoc Biol       Date:  1991-10       Impact factor: 4.962

8.  The biology of interleukin 1 and comparison to tumor necrosis factor.

Authors:  C A Dinarello
Journal:  Immunol Lett       Date:  1987-12       Impact factor: 3.685

9.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.

Authors:  B P Mahon; B J Sheahan; F Griffin; G Murphy; K H Mills
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

View more
  15 in total

1.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

5.  Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.

Authors:  S Donnelly; C E Loscher; M A Lynch; K H Mills
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Authors:  Gordon Y C Cheung; Dorothy Xing; Sandra Prior; Michael J Corbel; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

7.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

9.  Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Authors:  Maria Leonor S Oliveira; Eliane N Miyaji; Daniela M Ferreira; Adriana T Moreno; Patricia C D Ferreira; Fernanda A Lima; Fernanda L Santos; Maria Aparecida Sakauchi; Célia S Takata; Hisako G Higashi; Isaías Raw; Flavia S Kubrusly; Paulo L Ho
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

Review 10.  Review of the neutrophil response to Bordetella pertussis infection.

Authors:  Joshua C Eby; Casandra L Hoffman; Laura A Gonyar; Erik L Hewlett
Journal:  Pathog Dis       Date:  2015-10-02       Impact factor: 3.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.